How has Arvinas's operating lease liability payments - 2024 (lessee) changed year-over-year?

Arvinas's operating lease liability payments - 2024 (lessee) increased by 4.2% year-over-year, from $2.4M to $2.5M.

Arvinas ARVN Operating Lease Liability Payments - 2024 (Lessee)

Operating Lease Liability Payments - 2024 (Lessee) at other companies

Nurix Therapeutics, Inc.NRIX

——

Inhibrx Biosciences, Inc.INBX

——

Nuvation BioNUVB

——

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's operating lease liability payments - 2024 (lessee).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's operating lease liability payments - 2024 (lessee)?: Arvinas (ARVN) reported operating lease liability payments - 2024 (lessee) of $2.5M in Q1 2026.
How has Arvinas's operating lease liability payments - 2024 (lessee) changed year-over-year?: Arvinas's operating lease liability payments - 2024 (lessee) increased by 4.2% year-over-year, from $2.4M to $2.5M.